Singular Genomics Systems, Inc. (OMIC)

NASDAQ: OMIC · IEX Real-Time Price · USD
0.610
+0.060 (10.91%)
At close: Feb 26, 2024, 4:00 PM
0.620
+0.010 (1.64%)
After-hours: Feb 26, 2024, 7:48 PM EST
10.91%
Market Cap 44.76M
Revenue (ttm) 2.60M
Net Income (ttm) -92.67M
Shares Out 73.38M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 234,126
Open 0.566
Previous Close 0.550
Day's Range 0.552 - 0.615
52-Week Range 0.310 - 2.270
Beta 1.33
Analysts Hold
Price Target 0.85 (+39.34%)
Earnings Date Mar 8, 2024

About OMIC

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for app... [Read more]

Sector Healthcare
IPO Date May 27, 2021
Employees 284
Stock Exchange NASDAQ
Ticker Symbol OMIC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for OMIC stock is "Hold" and the 12-month stock price forecast is $0.85.

Price Target
$0.85
(39.34% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

21 days ago - GlobeNewsWire

Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

21 days ago - GlobeNewsWire

Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

7 weeks ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

3 months ago - GlobeNewsWire

Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

4 months ago - GlobeNewsWire

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc...

6 months ago - GlobeNewsWire

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: BIVIGRTXISPCME
6 months ago - Benzinga

Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results

SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

7 months ago - GlobeNewsWire

Singular Genomics Announces Participation in the UBS MedTech, Tools and Genomics Summit

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

7 months ago - GlobeNewsWire

Singular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023

SAN DIEGO, July 26, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

7 months ago - GlobeNewsWire

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

SAN DIEGO, June 01, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

9 months ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results

SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researche...

10 months ago - GlobeNewsWire

Singular Genomics to Report First Quarter 2023 Financial Results on May 9, 2023

SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc...

10 months ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results

SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc...

1 year ago - GlobeNewsWire

Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT

The datasets are the latest to validate the performance and plug-and-play capability of the G4 across multiple applications The datasets are the latest to validate the performance and plug-and-play ca...

1 year ago - GlobeNewsWire

Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT

- New next-generation sequencing kit maximizes throughput and decreases the cost for single cell experiments -

1 year ago - GlobeNewsWire

Singular Genomics Joins the 10x Genomics Compatible Partner Program

– Demonstrates compatibility of the G4 Sequencing Platform with 10x Genomics Single Cell Applications –

1 year ago - GlobeNewsWire

Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue

SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results

SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022

SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire

Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Presentation now scheduled for 1:30 p.m. PT on Wednesday, August 31, 2022 Presentation now scheduled for 1:30 p.m. PT on Wednesday, August 31, 2022

1 year ago - GlobeNewsWire

Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

1 year ago - GlobeNewsWire